SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-090039
Filing Date
2022-03-30
Accepted
2022-03-30 17:17:04
Documents
19
Period of Report
2022-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d321650d8k.htm   iXBRL 8-K 28774
2 EX-1.1 d321650dex11.htm EX-1.1 268225
3 EX-5.1 d321650dex51.htm EX-5.1 11833
4 EX-99.1 d321650dex991.htm EX-99.1 7915
5 EX-99.2 d321650dex992.htm EX-99.2 7551
9 GRAPHIC g321650dsp091.jpg GRAPHIC 25987
10 GRAPHIC g321650dsp092.jpg GRAPHIC 7604
11 GRAPHIC g321650g82m92.jpg GRAPHIC 4228
  Complete submission text file 0001193125-22-090039.txt   581610

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA igms-20220329.xsd EX-101.SCH 2842
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20220329_lab.xml EX-101.LAB 17979
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20220329_pre.xml EX-101.PRE 11249
13 EXTRACTED XBRL INSTANCE DOCUMENT d321650d8k_htm.xml XML 3351
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 22787693
SIC: 2834 Pharmaceutical Preparations